SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-036537
Filing Date
2024-03-26
Accepted
2024-03-26 17:00:36
Documents
88
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apto-20231231.htm   iXBRL 10-K 2055837
2 EX-21.1 apto-ex21_1.htm EX-21.1 4824
3 EX-23.1 apto-ex23_1.htm EX-23.1 10398
4 EX-31.1 apto-ex31_1.htm EX-31.1 12758
5 EX-31.2 apto-ex31_2.htm EX-31.2 12832
6 EX-32.1 apto-ex32_1.htm EX-32.1 5984
7 EX-32.2 apto-ex32_2.htm EX-32.2 6078
8 EX-97.1 apto-ex97_1.htm EX-97.1 46591
9 GRAPHIC img210773660_0.jpg GRAPHIC 4269
10 GRAPHIC img238830913_0.jpg GRAPHIC 70040
11 GRAPHIC img238830913_1.jpg GRAPHIC 8556
12 GRAPHIC img238830913_2.jpg GRAPHIC 4269
  Complete submission text file 0000950170-24-036537.txt   8940032

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apto-20231231.xsd EX-101.SCH 1248488
92 EXTRACTED XBRL INSTANCE DOCUMENT apto-20231231_htm.xml XML 1490375
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32001 | Film No.: 24784474
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)